Advancing Telestroke Care: A Prospective Observational Study
Launched by NATIONAL STROKE ASSOCIATION, UNITED STATES · Oct 21, 2010
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
The goal of this study is to promote the development and economic sustainability of telemedicine for acute stroke treatment. The study's objectives are 1) to determine if the use of telemedicine consultations for stroke patients will improve their care per guidelines compared to stroke patients treated by control hospitals; and 2) to determine if the care per guidelines provided via telemedicine consultations for stroke patients will be similar or equivalent to care per guidelines provided to stroke patients treated at hub hospitals.
The Advancing Telestroke Care study will establish treat...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age greater than or equal to 18 years old
- • Acute ischemic stroke within 12 hours of stroke onset
- Exclusion Criteria:
- • Life expectancy less than 90 days
- • Patient unwilling to participate in study
About National Stroke Association, United States
The National Stroke Association (NSA) is a prominent non-profit organization in the United States dedicated to advancing stroke care and improving outcomes for stroke patients. Through rigorous research funding, advocacy, and educational initiatives, the NSA aims to raise awareness about stroke prevention, treatment, and rehabilitation. As a clinical trial sponsor, the organization plays a crucial role in facilitating innovative studies that contribute to evidence-based practices and enhance the understanding of stroke-related health issues. By collaborating with healthcare professionals, researchers, and stakeholders, the National Stroke Association strives to drive progress in stroke research and improve the quality of life for individuals affected by stroke.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Gene Sung, MD, MPH
Principal Investigator
University of Southern California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials